Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
James Murray
et al. | Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib | 2017 |
|
Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
Dr Angelika Kaufmann
et al. | Defects in non-homologous end joining pathway in ovarian cancers results in resistance to rucaparib | 2015 |
|
Dr Aiste McCormick
Michelle Dixon
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Professor Richard Edmondson
et al. | PTEN function is important in determining ovarian cancer sensitivity to cytotoxic agents | 2015 |
|
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Evan Mulligan
James Murray
Professor Nicola Curtin
et al. | Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer | 2014 |
|
Dr Rachel O'Donnell
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Angelika Kaufmann
et al. | The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis | 2014 |
|
Dr Rachel O'Donnell
Laura Woodhouse
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
et al. | Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample? | 2013 |
|
